LUCY Innovative Eyewear, Inc.
Healthcare$1.02+0.00%ClosedMarket Cap: $4.1M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.76
P/S
1.37
EV/EBITDA
0.03
DCF Value
$-21.04
FCF Yield
-187.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
17.5%
Operating Margin
-300.7%
Net Margin
-272.5%
ROE
-83.4%
ROA
-85.7%
ROIC
-106.4%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $773.6K | 22.7% | $-2.4M | $-2.3M | $— | — |
| Q4 null | $959.8K | 12.0% | $-2.5M | $-1.9M | $— | — |
| FY null | $2.7M | 21.3% | $-8.5M | $-7.6M | $— | — |
| Q3 null | $668.1K | 36.6% | $-1.9M | $-1.8M | $— | — |
| Q2 null | $579.2K | -2.2% | $-2.2M | $-2.1M | $— | — |
| Q1 null | $454.5K | 48.5% | $-1.9M | $-1.8M | $— | — |
| Q4 null | $690.7K | 13.6% | $-2.2M | $-2.1M | $— | — |
| FY null | $1.6M | 13.1% | $-7.9M | $-7.8M | $— | — |
| Q3 null | $253.6K | 23.4% | $-1.8M | $-1.7M | $— | — |
| Q2 null | $308.7K | 17.9% | $-2.0M | $-1.9M | $— | — |
| Q1 null | $383.5K | 1.8% | $-2.0M | $-2.0M | $— | — |
| Q4 2023 | $615.8K | -29.3% | $-2.5M | $-2.4M | $-3.70 | — |